[ad_1]
“I see it as an existing STT legal experiment … it appears that any legal economic activity in Lithuania may lead to a visit to you,” the suspect told reporters in court on Wednesday.
“I don’t think there is really any crime,” he said.
On Wednesday, the Vilnius City District Court sentenced Š.Narbutas to preventive detention for a month, and was also prohibited from communicating with certain people, including representatives of the Ministry of Health.
Š.Narbutas 5 million suspected. He acted as an informal intermediary between the Lithuanian authorities and a foreign company in the acquisition of reagents worth 1 million euros, and it is also suspected that he may have appointed a certain amount to the representative of the company to mediate in this acquisition.
According to data from the pre-trial investigation, after the purchases had already taken place, more than LTL 300,000 was transferred to Š.Narbutas’ personal bank account multiple times. quantity.
It seems that any legal economic activity carried out in Lithuania can lead to a visit to you, – said Š.Narbutas.
The suspect claims to have received this amount legally.
“This is a contract-based commercial representation fee, which I performed with an individual activity certificate in accordance with properly drawn codes, entered into a contract, issued invoices, on my own initiative, submitted documents supporting the origin of the funds to the bank, adding contracts, invoices, “said Š.Narbutas. .
He claimed to be a former representative of the company that sold the reagents to Lithuania, an agent, under the contract signed in early March.
“The contract was concluded on March 1, did not specify that sales to Lithuania, a specific quota of 300 thousand. The reagents for sale in the European Union, as negotiations were ongoing with Slovakia at the time, it seems Finland and Belgium, “said the suspect.
According to him, the Spanish company was not the only one that offered the ministry for the purchase of reagents, but was the company that offered the lowest price.
“I provided the ministry with information on at least four different providers: South Korea, China and Turkey, that’s what the ministry chose,” Narbut said.
He claimed that the company had offered an email. mail and phone calls.
“Email, followed by calls. Now I can say that there was the Vice Minister Garuolienė, she was the director of the National Laboratory of Public Health, the deputies seem to me to be Aurelijus Veryga at a later stage, and Saulius Skvernelis, Algirdas Stončaitis, Lukas Savickas, it was a very wide circle of people, “said the suspect.
Narbutas added that the representatives of the Ministry of Health and the witnesses interviewed in the investigation knew that he represented a Spanish company.
“The ministry and all the individuals, as well as the witnesses mentioned in these documents, made it clear that they understood that I was a mediator. In fact, no one asked me if you do it for a fee, and apparently this is an episode, ”said S. Narbutas.
Narbutas added that the representatives of the Ministry of Health and the witnesses interviewed in the investigation knew that he represented a Spanish company.
He added that the Spanish company had approached him and that he had been contacted by acquaintances through the Whats application.
Narbut also claimed that all of his bills and his car were currently seized, among other things, he stated that he was considering resigning the president of POLA and other public charges due to damage to his reputation.
According to BNS, the researchers explain the two contracts signed by the National Laboratory of Public Health on March 21 and 23 of this year with the Spanish company PMS International.
The central procurement portal indicates that the laboratory has concluded two measurement contracts for COVID-19 research: one is 3.5 million. 1.8 million euros. euros
The two contracts for the supply of reagents from China were signed by the then head of the laboratory, Vytautas Zimnickas, who died a week ago. The agreements have been signed with a representative of PMS International, whose name is not indicated in the agreement.
Under the agreements, part of the funds had to be transferred to the Chinese reagent manufacturer Sansure Biotech.
[ad_2]
